CL2008000931A1 - Cross-linked oral vaccine solids containing a pharmaceutically active ingredient, a bioadhesive, an oligasacaride, a mediator mixture comprising an emulsifier and one or more monosaccharides and / or disacarids; method for its preparation; use of solida oral vaccine particle. - Google Patents
Cross-linked oral vaccine solids containing a pharmaceutically active ingredient, a bioadhesive, an oligasacaride, a mediator mixture comprising an emulsifier and one or more monosaccharides and / or disacarids; method for its preparation; use of solida oral vaccine particle.Info
- Publication number
- CL2008000931A1 CL2008000931A1 CL2008000931A CL2008000931A CL2008000931A1 CL 2008000931 A1 CL2008000931 A1 CL 2008000931A1 CL 2008000931 A CL2008000931 A CL 2008000931A CL 2008000931 A CL2008000931 A CL 2008000931A CL 2008000931 A1 CL2008000931 A1 CL 2008000931A1
- Authority
- CL
- Chile
- Prior art keywords
- oral vaccine
- active ingredient
- pharmaceutically active
- bioadhesive
- oligasacaride
- Prior art date
Links
Abstract
Composición para la administración oral a un animal para la liberación intestinal de un ingrediente farmacéuticamente activo que comprende al menos un polímero bioadhesivo, al menos un oligosacárido y al menos un compuesto mediador; uso de la composición para preparar una vacuna oral para un animal.Composition for oral administration to an animal for intestinal release of a pharmaceutically active ingredient comprising at least one bioadhesive polymer, at least one oligosaccharide and at least one mediator compound; use of the composition to prepare an oral vaccine for an animal.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2008000931A CL2008000931A1 (en) | 2008-03-31 | 2008-03-31 | Cross-linked oral vaccine solids containing a pharmaceutically active ingredient, a bioadhesive, an oligasacaride, a mediator mixture comprising an emulsifier and one or more monosaccharides and / or disacarids; method for its preparation; use of solida oral vaccine particle. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2008000931A CL2008000931A1 (en) | 2008-03-31 | 2008-03-31 | Cross-linked oral vaccine solids containing a pharmaceutically active ingredient, a bioadhesive, an oligasacaride, a mediator mixture comprising an emulsifier and one or more monosaccharides and / or disacarids; method for its preparation; use of solida oral vaccine particle. |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008000931A1 true CL2008000931A1 (en) | 2008-11-07 |
Family
ID=51399071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2008000931A CL2008000931A1 (en) | 2008-03-31 | 2008-03-31 | Cross-linked oral vaccine solids containing a pharmaceutically active ingredient, a bioadhesive, an oligasacaride, a mediator mixture comprising an emulsifier and one or more monosaccharides and / or disacarids; method for its preparation; use of solida oral vaccine particle. |
Country Status (1)
Country | Link |
---|---|
CL (1) | CL2008000931A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9623094B2 (en) | 2009-03-27 | 2017-04-18 | Advanced Bionutrition Corporation | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
US9737578B2 (en) | 2005-12-28 | 2017-08-22 | Advanced Bionutrition Corp. | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
US10206421B2 (en) | 2010-01-28 | 2019-02-19 | Advanced Bionutrition Corp. | Stabilizing composition for biological materials |
US10953050B2 (en) | 2015-07-29 | 2021-03-23 | Advanced Bionutrition Corp. | Stable dry probiotic compositions for special dietary uses |
-
2008
- 2008-03-31 CL CL2008000931A patent/CL2008000931A1/en unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9737578B2 (en) | 2005-12-28 | 2017-08-22 | Advanced Bionutrition Corp. | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
US9623094B2 (en) | 2009-03-27 | 2017-04-18 | Advanced Bionutrition Corporation | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
US10206421B2 (en) | 2010-01-28 | 2019-02-19 | Advanced Bionutrition Corp. | Stabilizing composition for biological materials |
US10953050B2 (en) | 2015-07-29 | 2021-03-23 | Advanced Bionutrition Corp. | Stable dry probiotic compositions for special dietary uses |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2009001766A1 (en) | Solid pharmaceutical composition for oral administration comprising: a defined substantially amorphous taxane, a defined hydrophilic carrier and a defined surfactant; method of preparing the composition; and its use to treat neoplastic disease. | |
GT201000095A (en) | SOLID DISPERSION PRODUCT CONTAINING A N-ARIL UREA-BASED COMPOUND | |
CL2013001586A1 (en) | Rapid dispersion microgranular composition comprising at least one sugar alcohol, a saccharide, or a mixture thereof, at least one super disintegrant and at least one multifunctional additive; oral disintegration tablet comprising the microgranular composition and at least one active ingredient; and manufacturing methods. | |
CL2007002018A1 (en) | COMPOUNDS DERIVED FROM SUBSTITUTED ISOXAZOLINS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND FOR THE TREATMENT OF A DISEASE CAUSED BY AN INCREASE IN THE CELL PROLIFERATION. | |
PE20142192A1 (en) | PHARMACEUTICAL DOSAGE FORM INCLUDING NIFEDIPINE OR NISOLDIPINE AND AN ANGIOTENSIN II ANTAGONIST AND / OR DIURETIC | |
SV2009002857A (en) | SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF ACTIVE PRINCIPLE | |
AR060755A1 (en) | FORMULATIONS OF DIPEPTIDIL PEPTIDASA IV INHIBITORS (DPP IV) | |
BRPI0814666A2 (en) | pharmaceutical composition for oral administration, use of a formulation. process for preparing a solid dosage form, and, solid dosage form | |
BR112017008993A2 (en) | Methods and Compositions Specifically for the Treatment of Attention Deficit Disorder | |
BRPI1007945B8 (en) | pharmaceutical formulation of controlled release of nitazoxamide, tizoxanide or a combination thereof, and bilayer tablet for oral administration | |
CL2011000558A1 (en) | Crystalline forms of a compound derived from 2-thiazolyl-4-quinolinyl-oxy; Sodium salt of the compound, pharmaceutical composition comprising sodium salt, useful for treating hepatitis C virus infection. | |
AR047993A1 (en) | PHARMACEUTICAL COMPOSITION THAT PIMOBENDAN INCLUDES | |
CL2011002858A1 (en) | Use of an oral transmucosal pharmaceutical composition comprising dexmedetomidine and a pharmaceutically acceptable salt and a pharmaceutically acceptable excipient to prepare a medicament useful for treating or preventing pain. | |
CL2007001917A1 (en) | COMPOUNDS DERIVED FROM SIPROCICLIC AZAINDOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, CONDITIONS OF PANIC, DEPRESSION, EVIL OF ALZHEIMER, MIGRANA, AMONG OTHERS. | |
NO20074933L (en) | Pharmaceutical composition comprising an indolylmaleimide derivative | |
ECSP10010588A (en) | FORMULATION OF SOLID DRUG WITH DELAYED RELEASE | |
IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
BRPI0807285A2 (en) | "COMPOSITION, METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION, UNIT FORM OF DOSAGE, METHOD FOR ADMINISTRATING A BIOLOGICAL ACTIVE AGENT NEEDING THE AGENT, METHOD FOR INCREASING BIODISPONABILITY FOR PREPARING AN AGENT OF COMPOSITION" | |
BR112012003280A2 (en) | pharmaceutical composition for oral administration, method for treating a disease, use of the compound, and, compound. | |
NO20082047L (en) | Slow release composition, process for its preparation and use thereof | |
WO2007025182A3 (en) | Drug compositions containing controlled release hypromellose matrices | |
NZ597317A (en) | Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application | |
TN2015000135A1 (en) | Modified release formulations for oprozomib | |
BRPI0810025A2 (en) | ORAL PHARMACEUTICAL FORMULATION FOR IMMEDIATE RELEASE, METHOD FOR PREPARING A MULTIPARTICULATED PHARMACEUTICAL FORMULATION, AND USE OF URSODESOXICOLIC ACID | |
CL2008000931A1 (en) | Cross-linked oral vaccine solids containing a pharmaceutically active ingredient, a bioadhesive, an oligasacaride, a mediator mixture comprising an emulsifier and one or more monosaccharides and / or disacarids; method for its preparation; use of solida oral vaccine particle. |